At the time of writing, Edgewise Therapeutics Inc [EWTX] stock is trading at $28.01, down -0.43%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The EWTX shares have gain 7.03% over the last week, with a monthly amount drifted -6.73%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Edgewise Therapeutics Inc [NASDAQ: EWTX] stock has seen the most recent analyst activity on March 07, 2025, when Scotiabank initiated its Sector Outperform rating and assigned the stock a price target of $50. Previously, Stifel started tracking the stock with Hold rating on January 22, 2025, and set its price target to $30. On November 22, 2024, Evercore ISI initiated with a Outperform rating and assigned a price target of $45 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $48 on March 07, 2024. Truist initiated its recommendation with a Buy. Goldman downgraded its rating to Sell for this stock on August 25, 2022, but kept the price target unchanged to $5. In a note dated April 13, 2022, RBC Capital Mkts initiated an Outperform rating and provided a target price of $31 on this stock.
For the past year, the stock price of Edgewise Therapeutics Inc fluctuated between $14.90 and $38.12. Currently, Wall Street analysts expect the stock to reach $46.25 within the next 12 months. Edgewise Therapeutics Inc [NASDAQ: EWTX] shares were valued at $28.01 at the most recent close of the market. An investor can expect a potential return of 65.12% based on the average EWTX price forecast.
Analyzing the EWTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.27 and Total Capital is -0.34. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 27.03 points at the first support level, and at 26.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 29.51, and for the 2nd resistance point, it is at 31.02.
Ratios To Look Out For
It is important to note that Edgewise Therapeutics Inc [NASDAQ:EWTX] has a current ratio of 19.93. Also, the Quick Ratio is 19.93, while the Cash Ratio stands at 1.75.
Transactions by insiders
Recent insider trading involved Russell Alan J, Chief Scientific Officer, that happened on Feb 05 ’25 when 8015.0 shares were sold. Chief Scientific Officer, Russell Alan J completed a deal on Feb 06 ’25 to sell 1200.0 shares. Meanwhile, President and CEO KOCH KEVIN sold 8636.0 shares on Feb 05 ’25.
